Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Baltimore, MD 21287, USA.
Neuroimaging Clin N Am. 2010 Aug;20(3):293-310. doi: 10.1016/j.nic.2010.04.003.
The utility of magnetic resonance spectroscopy (MRS) in diagnosis and evaluation of treatment response to human brain tumors has been widely documented. The role of MRS in tumor classification, tumors versus nonneoplastic lesions, prediction of survival, treatment planning, monitoring of therapy, and post-therapy evaluation is discussed. This article delineates the need for standardization and further study in order for MRS to become widely used as a routine clinical tool.
磁共振波谱(MRS)在诊断和评估人脑肿瘤的治疗反应方面的应用已被广泛记录。本文讨论了 MRS 在肿瘤分类、肿瘤与非肿瘤性病变、预测生存、治疗计划、治疗监测以及治疗后评估中的作用。本文阐述了需要进行标准化和进一步研究,以使 MRS 成为广泛应用的常规临床工具。